After reviewing the latest quarterly results from Medexus Pharmaceuticals, Roth Capital Partners analyst Scott R. Henry is sticking with a bullish call on the stock.
Roth Capital Partners analyst Scott R. Henry provided an update on Tuesday on medical device company Sensus Healthcare, saying the stock may be in for a rebound.
/PRNewswire/ NEXGEL, Inc. (NASDAQ: NXGL, NXGLW), ("NEXGEL" or the "Company"), a leading provider of ultra-gentle, high-water-content hydrogel products for.